Adherence Trajectories to Statins and Antithrombotic Therapy After Ischemic Stroke and Cardiovascular Outcomes

This longitudinal study of over 13,000 stroke survivors identified four distinct patterns of adherence to secondary prevention medications, ranging from sustained high adherence to early or gradual discontinuation. Patients maintaining dual high adherence to both statins and antithrombotic agents achieved the best lipid control and lowest mortality, while those with early discontinuation faced significantly elevated risks of recurrent stroke and other cardiovascular events.